The biopharmaceutical studies of Valavir film-coated tablets, 0.5 g
DOI:
https://doi.org/10.24959/nphj.15.2069Keywords:
biopharmaceutical studies, bioavailability, bioequivalence, test drug product, reference drug product, Valavir 0.5 g film-coated tabletsAbstract
The biopharmaceutical studies of Valavir film-coated tablets, 0.5 g, with valaciclovir hydrochloride have been substantiated in the article. The biopharmaceutical studies have been conducted in vitro; the dissolution profiles of Valavir film-coated tablets, 0.5 g, and the reference drug Valtrex (film-coated tablets, 500 mg, manufactured by GlaxoSmithKline Pharmaceuticals S.A., Poland) have been compared by the method for Dissolution Kinetics. The results of the experimental study in vivo, namely the value of Cmax, AUC0-t and other values confirm that Valavir film-coated tablets, 0.5 g, manufactured by Farmak JSC is bioequivalent to the reference drug Valtrex film-coated tablets, 500 mg, (GlaxoSmithKline Pharmaceuticals S.A., Poland).References
- Государственная фармакопея Украины / Государственное предприятие «Научно-экспертный фармакопейный центр». – Х.: РІРЕГ, 2001. – 556 с.
- Гуреєва С.М. // Укр. журн. лабораторної та клін. медицини. – 2012. – Т. 7, №3. – С. 6-10.
- Гуреєва С.М., Заїдзе А.В. Стельмах А.М., Яковенко О.М. // Фармац. часопис. – 2011. – №4(20). – С. 68-72.
- Amini H., Javan M., Gazerani P. et al. // Clin. Drug Invest. – 2008. – Vol. 28(1). –P. 47-53.
- Rajni Bala, Pravin Pawar, Sushil Khanna et al. // Intern. J. of Pharmac. Investigation. – 2013. – Vol. 3, Iss. 2. – P. 67-76.
- Zhang Zhi-Rong, He Qin // World J. of Gastroenterol. (WJG). – 1999. – August. – Vol. 5(4). – P. 330-333.
Downloads
Published
2015-12-02
Issue
Section
Technology of Medicines
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
